P
Pratibha Mistry
Researcher at Syngenta
Publications - 19
Citations - 1740
Pratibha Mistry is an academic researcher from Syngenta. The author has contributed to research in topics: DNA damage & Vitamin C. The author has an hindex of 13, co-authored 19 publications receiving 1623 citations. Previous affiliations of Pratibha Mistry include University of Leicester & Exponent.
Papers
More filters
Journal ArticleDOI
Vitamin C exhibits pro-oxidant properties
Ian D. Podmore,Helen R. Griffiths,Karl E. Herbert,Nalini Mistry,Pratibha Mistry,Joseph Lunec +5 more
TL;DR: It is reported here that vitamin C administered as a dietary supplement to healthy humans exhibits a pro-oxidant, as well as an antioxidant, effect in vivo.
Journal ArticleDOI
Novel repair action of vitamin C upon in vivo oxidative DNA damage
Marcus S. Cooke,Mark D. Evans,Ian D. Podmore,Karl E. Herbert,Nalini Mistry,Pratibha Mistry,Peter T. Hickenbotham,Amina Hussieni,Helen R. Griffiths,Joseph Lunec +9 more
TL;DR: The kinetics of 8‐oxo‐2′‐deoxyguanosine removal and processing in vivo are illustrated, for the first time in humans, suggesting a role for vitamin C in the regulation of DNA repair enzymes and thereby demonstrating a non‐scavenging antioxidant effect.
Journal ArticleDOI
Molecular and cellular effects of ultraviolet light-induced genotoxicity.
TL;DR: The cell cycle is restricted via p53-dependent and -independent pathways to facilitate repair processes prior to replication and division, and failure to rescue the cell from replication block will ultimately lead to cell death, and apoptosis may be induced.
Journal ArticleDOI
p38 Mitogen-Activated Protein Kinase Mediates Cell Death and p21-Activated Kinase Mediates Cell Survival during Chemotherapeutic Drug-induced Mitotic Arrest
TL;DR: It is provided new evidence that both cell survival and cell death-signaling pathways are concomitantly activated during mitotic arrest by microtubule-interfering drugs, and therapeutic strategies that suppress PAK-mediated survival signals may improve the efficacy of current cancer chemotherapies by enhancing p38 MAPK- mediated cell death.
Journal ArticleDOI
Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity
TL;DR: This study characterises cellular growth, bioenergetics and mitochondrial toxicity of the L6 rat skeletal muscle cell line cultured in either high glucose or galactose media and confirms that L6 cells are able to adapt to growth in a galactOSE media model and are consequently more susceptible to mitochondrial toxicants.